Related Articles
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy
Subcutaneous recombinant interleukin-2 plus alpha interferon and vinblastine in metastatic renal cell carcinoma
TUMOR RESPONSE AND 4 YEAR SURVIVAL-DATA OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH AUTOLOGOUS TUMOR VACCINE AND SUBCUTANEOUS R-IL-2 AND IFN-ALPHA(2B)
FEC (FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE) PLUS GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED OR INFLAMMATORY BREAST-CANCER - A DOSE-FINDING STUDY
RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA-2A IN PRETREATED ADVANCED SOFT-TISSUE SARCOMAS